Filing Details
- Accession Number:
- 0001567619-19-000984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-10 18:32:38
- Reporting Period:
- 2018-12-17
- Accepted Time:
- 2019-01-10 18:32:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598292 | Ecor1 Capital Fund Qualified, L.p. | 409 Illinois Street San Francisco CA 94158 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-12-17 | 26,520 | $13.20 | 4,194,209 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-12-18 | 78,469 | $13.82 | 4,272,678 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-12-19 | 51,879 | $13.84 | 4,324,557 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-12-21 | 83,540 | $13.16 | 4,408,097 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |